Lineage Cell Therapeutics Stock Price History
| LCTX Stock | USD 0.51 0.01 2.00% |
Below is the normalized historical share price chart for Lineage Cell Therapeutics extending back to March 05, 1992. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lineage Cell stands at 0.51, as last reported on the 23rd of March, with the highest price reaching 0.54 and the lowest price hitting 0.49 during the day.
If you're considering investing in Lineage Stock, it is important to understand the factors that can impact its price. At this stage we consider Lineage Stock to be dangerous. Lineage Cell Therapeutics has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Lineage Cell, which you can use to evaluate the volatility of the firm. Please verify Lineage Cell's Mean Deviation of 3.76, risk adjusted performance of 0.0307, and Downside Deviation of 4.63 to check out if the risk estimate we provide is consistent with the expected return of 0.0092%.
At this time, Lineage Cell's Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 210.2 M in 2025, despite the fact that Other Stockholder Equity is likely to grow to (1.3 M). . At this time, Lineage Cell's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.25 in 2025, whereas Price To Sales Ratio is likely to drop 10.06 in 2025. Lineage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of March 1992 | 200 Day MA 0.7777 | 50 Day MA 0.5994 | Beta 1.278 |
Lineage |
Sharpe Ratio = 0.0017
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LCTX |
Estimated Market Risk
| 5.27 actual daily | 47 53% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lineage Cell is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lineage Cell by adding Lineage Cell to a well-diversified portfolio.
Price Book 1.4756 | Enterprise Value Ebitda (8.84) | Price Sales 12.1763 | Shares Float 177.8 M | Wall Street Target Price 4.1667 |
Lineage Cell Stock Price History Chart
There are several ways to analyze Lineage Stock price data. The simplest method is using a basic Lineage candlestick price chart, which shows Lineage Cell price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 18, 2025 | 0.72 |
| Lowest Price | March 18, 2025 | 0.48 |
Lineage Cell March 23, 2025 Stock Price Synopsis
Various analyses of Lineage Cell's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Lineage Stock. It can be used to describe the percentage change in the price of Lineage Cell from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Lineage Stock.| Lineage Cell Price Rate Of Daily Change | 1.02 | |
| Lineage Cell Price Daily Balance Of Power | 0.20 |
Lineage Cell March 23, 2025 Stock Price Analysis
Lineage Stock Price History Data
The price series of Lineage Cell for the period between Mon, Dec 23, 2024 and Sun, Mar 23, 2025 has a statistical range of 0.24 with a coefficient of variation of 12.22. The daily prices for the period are spread out with arithmetic mean of 0.58. The median price for the last 90 days is 0.57. The company underwent 3:1 stock split on 31st of October 1997.| Open | High | Low | Close | Volume | ||
03/23/2025 | 0.50 | 0.54 | 0.49 | 0.51 | ||
| 03/21/2025 | 0.50 | 0.54 | 0.49 | 0.51 | 6,412,406 | |
| 03/20/2025 | 0.49 | 0.53 | 0.49 | 0.50 | 1,996,067 | |
| 03/19/2025 | 0.48 | 0.53 | 0.48 | 0.49 | 1,230,978 | |
| 03/18/2025 | 0.50 | 0.51 | 0.48 | 0.48 | 2,410,719 | |
| 03/17/2025 | 0.53 | 0.53 | 0.50 | 0.50 | 2,856,441 | |
| 03/14/2025 | 0.52 | 0.55 | 0.52 | 0.52 | 875,497 | |
| 03/13/2025 | 0.54 | 0.56 | 0.52 | 0.52 | 2,221,367 | |
| 03/12/2025 | 0.53 | 0.55 | 0.52 | 0.52 | 1,680,580 | |
| 03/11/2025 | 0.54 | 0.55 | 0.50 | 0.53 | 1,716,210 | |
| 03/10/2025 | 0.55 | 0.58 | 0.51 | 0.53 | 1,880,812 | |
| 03/07/2025 | 0.55 | 0.56 | 0.52 | 0.53 | 855,166 | |
| 03/06/2025 | 0.52 | 0.57 | 0.51 | 0.53 | 1,953,484 | |
| 03/05/2025 | 0.53 | 0.55 | 0.52 | 0.52 | 1,545,023 | |
| 03/04/2025 | 0.51 | 0.56 | 0.50 | 0.53 | 1,166,791 | |
| 03/03/2025 | 0.58 | 0.59 | 0.51 | 0.51 | 1,327,419 | |
| 02/28/2025 | 0.57 | 0.60 | 0.55 | 0.56 | 1,179,374 | |
| 02/27/2025 | 0.64 | 0.65 | 0.57 | 0.57 | 1,664,512 | |
| 02/26/2025 | 0.65 | 0.67 | 0.61 | 0.63 | 785,433 | |
| 02/25/2025 | 0.67 | 0.68 | 0.63 | 0.64 | 884,015 | |
| 02/24/2025 | 0.69 | 0.69 | 0.66 | 0.66 | 642,404 | |
| 02/21/2025 | 0.72 | 0.73 | 0.68 | 0.68 | 758,014 | |
| 02/20/2025 | 0.72 | 0.72 | 0.69 | 0.69 | 353,606 | |
| 02/19/2025 | 0.74 | 0.75 | 0.71 | 0.72 | 683,071 | |
| 02/18/2025 | 0.70 | 0.75 | 0.70 | 0.72 | 1,411,648 | |
| 02/14/2025 | 0.69 | 0.70 | 0.66 | 0.69 | 800,763 | |
| 02/13/2025 | 0.65 | 0.70 | 0.65 | 0.69 | 1,007,467 | |
| 02/12/2025 | 0.65 | 0.67 | 0.63 | 0.64 | 596,917 | |
| 02/11/2025 | 0.67 | 0.67 | 0.63 | 0.65 | 836,599 | |
| 02/10/2025 | 0.68 | 0.70 | 0.65 | 0.66 | 940,119 | |
| 02/07/2025 | 0.70 | 0.71 | 0.67 | 0.67 | 744,836 | |
| 02/06/2025 | 0.71 | 0.73 | 0.69 | 0.70 | 1,214,787 | |
| 02/05/2025 | 0.69 | 0.71 | 0.66 | 0.71 | 1,133,766 | |
| 02/04/2025 | 0.69 | 0.72 | 0.64 | 0.66 | 1,709,389 | |
| 02/03/2025 | 0.60 | 0.72 | 0.60 | 0.69 | 4,195,597 | |
| 01/31/2025 | 0.63 | 0.68 | 0.58 | 0.60 | 1,784,241 | |
| 01/30/2025 | 0.62 | 0.64 | 0.61 | 0.63 | 614,319 | |
| 01/29/2025 | 0.68 | 0.68 | 0.60 | 0.60 | 2,431,045 | |
| 01/28/2025 | 0.63 | 0.63 | 0.60 | 0.63 | 736,782 | |
| 01/27/2025 | 0.64 | 0.65 | 0.60 | 0.62 | 773,806 | |
| 01/24/2025 | 0.66 | 0.66 | 0.61 | 0.64 | 1,074,249 | |
| 01/23/2025 | 0.68 | 0.69 | 0.62 | 0.63 | 1,229,793 | |
| 01/22/2025 | 0.60 | 0.69 | 0.60 | 0.68 | 3,022,244 | |
| 01/21/2025 | 0.59 | 0.60 | 0.58 | 0.59 | 7,334,297 | |
| 01/17/2025 | 0.58 | 0.59 | 0.55 | 0.59 | 715,237 | |
| 01/16/2025 | 0.58 | 0.58 | 0.56 | 0.57 | 343,997 | |
| 01/15/2025 | 0.56 | 0.59 | 0.55 | 0.58 | 841,894 | |
| 01/14/2025 | 0.59 | 0.59 | 0.54 | 0.55 | 1,297,526 | |
| 01/13/2025 | 0.58 | 0.60 | 0.55 | 0.60 | 1,755,141 | |
| 01/10/2025 | 0.55 | 0.58 | 0.51 | 0.58 | 1,669,282 | |
| 01/08/2025 | 0.57 | 0.57 | 0.53 | 0.53 | 1,089,293 | |
| 01/07/2025 | 0.56 | 0.58 | 0.56 | 0.58 | 1,343,498 | |
| 01/06/2025 | 0.60 | 0.61 | 0.54 | 0.55 | 2,394,610 | |
| 01/03/2025 | 0.54 | 0.59 | 0.50 | 0.59 | 5,587,948 | |
| 01/02/2025 | 0.51 | 0.53 | 0.50 | 0.52 | 12,159,510 | |
| 12/31/2024 | 0.50 | 0.51 | 0.49 | 0.50 | 2,379,717 | |
| 12/30/2024 | 0.50 | 0.51 | 0.48 | 0.50 | 1,782,878 | |
| 12/27/2024 | 0.51 | 0.54 | 0.50 | 0.50 | 2,167,609 | |
| 12/26/2024 | 0.54 | 0.54 | 0.50 | 0.51 | 3,016,492 | |
| 12/24/2024 | 0.55 | 0.55 | 0.53 | 0.54 | 890,725 | |
| 12/23/2024 | 0.56 | 0.57 | 0.53 | 0.55 | 948,941 |
About Lineage Cell Stock history
Lineage Cell investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lineage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lineage Cell Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lineage Cell stock prices may prove useful in developing a viable investing in Lineage Cell
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 200.2 M | 210.2 M | |
| Net Loss | -30.2 M | -31.7 M |
Lineage Cell Quarterly Net Working Capital |
|
Lineage Cell Stock Technical Analysis
Lineage Cell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Lineage Cell Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lineage Cell's price direction in advance. Along with the technical and fundamental analysis of Lineage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lineage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0307 | |||
| Jensen Alpha | 0.1621 | |||
| Total Risk Alpha | 0.5248 | |||
| Sortino Ratio | 0.0412 | |||
| Treynor Ratio | 0.216 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Lineage Stock Analysis
When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.